TYMS and prostate adenocarcinoma: A differential survival analysis carried out with GEPIA showed the correlation of ZWINT, CDK1, IGFPB3, and TYMS expression with disease-free survival (DFS) in a database of patients with prostate adenocarcinoma (Supplementary Figure S3).